Building a New Biomedical Ecosystem: Pfizer's Centers for Therapeutic Innovation

It is becoming increasingly clear that to significantly enhance research and development productivity and innovation, new external partnerships are essential. Although partnership between academia and industry is not a novel concept, the manner in which such collaborations are designed and implement...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical pharmacology and therapeutics 2013-09, Vol.94 (3), p.314-316
Hauptverfasser:	Patel, A C, Coyle, A J
Format:	Artikel
Sprache:	eng
Schlagworte:	Academies and Institutes - organization & administration Biological and medical sciences Drug Industry - organization & administration Medical sciences Organizational Innovation Pharmacology. Drug treatments Public-Private Sector Partnerships - organization & administration Translational Medical Research - methods Translational Medical Research - organization & administration
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	It is becoming increasingly clear that to significantly enhance research and development productivity and innovation, new external partnerships are essential. Although partnership between academia and industry is not a novel concept, the manner in which such collaborations are designed and implemented has evolved. In 2010, Pfizer took decisive steps to form the Centers for Therapeutic Innovation: a partnership model with academia based on true collaboration, reflected by transparency, shared decision making, and aligned incentives for sustainable innovation. Clinical Pharmacology & Therapeutics (2013); 94 3, 314–316. doi:10.1038/clpt.2013.89
ISSN:	0009-9236 1532-6535
DOI:	10.1038/clpt.2013.89